Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
Iuliia M. Gilchuk(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Natalie J. Thornburg(Oak Ridge Associated Universities), Sandhya Bangaru(Government Medical College), Pavlo Gilchuk(AstraZeneca (Japan)), Kathryn M. Edwards(Vanderbilt University Medical Center), Nurgun Kose(Vanderbilt University Medical Center), Hannah L. Turner(Scripps Research Institute), Ryan P. Irving(Vanderbilt University Medical Center), Robin Bombardi(Vanderbilt University Medical Center), Xueyong Zhu(Scripps Research Institute), C. Buddy Creech(Vanderbilt University), Andrew B. Ward(Scripps Research Institute), Wenli Yu(Scripps Research Institute), Sheng Li(University of California San Diego), Ian A. Wilson(Raigmore Hospital)
Cited by 73
Related Papers
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
The Burden of Respiratory Syncytial Virus Infection in Young Children
|New England Journal of Medicine|2009|2.3k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k